A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Global Ophthalmoscopes Market Report to 2030: Rising Incidence of Eye Diseases Drives Growth

The “Ophthalmoscopes Market Size, Share & Trends Analysis Report By Type (Direct, Indirect), By Application (Diabetic Retinopathy, Macular Degeneration, Retinal Repair, Glaucoma), By End-use (Hospitals), By Region, And Segment Forecasts, 2023 – 2030″ report has been added to ResearchAndMarkets.com’s offering.

The global ophthalmoscopes market size is expected to reach USD 408.7 million by 2030 to expand at a CAGR of 6.6% from 2023 to 2030.

Companies Mentioned

  • Welch Allyn
  • Keeler Ltd.co
  • Zumax medical co. ltd
  • Albert Waeschle
  • Neitz Instruments Co., Ltd.
  • US Ophthalmic
  • Heine USA Ltd
  • HONSUN Group
  • Rudolf Riester GmbH
  • Dino-Lite Europe

The increasing technological advancements in ophthalmic devices, the growing prevalence of eye disorders, and increasing healthcare expenditure, particularly in emerging economies, are the key factors driving the growth of the ophthalmoscopes market.

Portable ophthalmoscopes are handheld devices used to examine the eye’s interior including the retina, optic disc, and blood vessels. The growing demand for portable ophthalmoscopes is increasing due to their ease of use and convenience. They are typically used by optometrists, eye doctors, and other medical professionals.

Additionally, advancement in technology is also a primary factor contributing to the demand for ophthalmoscopes. Advancements in artificial intelligence (AI) and machine learning are being incorporated into ophthalmoscopes, allowing for the automatic detection and diagnosis of eye diseases. AI-powered ophthalmoscopes can analyze images of the retina and optic nerve, identifying patterns and anomalies that may be indicative of eye diseases.

More than 2.9 million Americans aged 40 and older have low vision. Nearly 4.2 million Americans aged 40 and older are visually impaired. Approximately 8% of men and 0.5% of women with Northern European ancestry have the most common form of color blindness that makes it hard to see red or green. Such a rise in the incidence of eye disorders across the globe is anticipated to propel market growth.

The key players are involved in strategies, such as entering into product launches, collaborations & agreements, and mergers & acquisitions, to expand its geographical presence.

For instance, in August 2022, Swaraashi Netralya announced the launch ophthalmic devices including ophthalmoscope to identify eye concerns among adults as well as children’s. The Mirante SLO/OCT, a scanning laser ophthalmoscope used to capture high-quality color images was launched in India.

Ophthalmoscopes Market Report Highlights

  • Direct ophthalmoscopes accounted for the largest market share in 2022 owing to rising usage for examining the optic disc, retina, and other structures at the back of the eye
  • Based on application, glaucoma accounted for the largest market share of 31.8% in 2022 and is the leading cause of blindness in the U.S. and across the globe
  • Ophthalmic clinics are anticipated to register the fastest CAGR growth during the forecast period
  • North America accounted for the largest share of 32.3% in 2022 owing to the growing prevalence of eye diseases & disorders and rising advancement

Key Attributes:

Report Attribute Details
No. of Pages 100
Forecast Period 2022 – 2030
Estimated Market Value (USD) in 2022 $245.2 Million
Forecasted Market Value (USD) by 2030 $408.7 Million
Compound Annual Growth Rate 6.6%
Regions Covered Global

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Ophthalmoscopes Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent market outlook

3.1.2. Related/ancillary market outlook

3.2. Market Dynamics

3.2.1. Market driver analysis Growing incidence of eye diseases Increasing technological advancements & government initiatives Increasing awareness about eye health Growing geriatric population

3.2.2. Market restraint analysis Limited availability & technological limitations High cost of ophthalmoscopes

3.3. Dental Regeneration: Market Analysis Tools

Chapter 4. Ophthalmoscopes Market: Type Estimates & Trend Analysis

Chapter 5. Ophthalmoscopes Market: Application Estimates & Trend Analysis

Chapter 6. Ophthalmoscopes Market: End-use Estimates & Trend Analysis

Chapter 7. Ophthalmoscopes Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

8.1. Company Profiles

For more information about this report visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.
“We are excited to present the first look at the safety and clinical activity of ELVN-001, which we believe supports the potential for ELVN-001 to address the limitations of the available active-site TKIs,” said Helen Collins, M.D., Chief Medical Officer of Enliven. “Across a wide dose range, ELVN-001 demonstrated activity in a heavily pre-treated patient population that includes post-asciminib patients, with a preliminary safety profile consistent with its highly selective design. Not only did all evaluable patients have improved or stable BCR::ABL1 transcript levels, but, importantly, 89% of all patients enrolled remain on study. We believe the initial data demonstrate the potential clinical utility of ELVN-001 for all types of patients, including those that are earlier in the treatment paradigm.”
The partnership is with Health-HavenRx ™, an online pharmacy platform. This partnership enables a new, convenient channel for patients to access POGO Automatic by using their health insurance on Intuity Medical’s e-commerce website at www.GoodtoPogo.com.

By using this website you agree to accept Medical Device News Magazine Privacy Policy